All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Acute bronchitis therapy with ivy leaves extracts in a two-arm study: A double-blind, randomised study vs. an other ivy leaves extract

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F11%3A00003464" target="_blank" >RIV/00216208:11120/11:00003464 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064173:_____/11:#0000424

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.phymed.2011.06.014" target="_blank" >http://dx.doi.org/10.1016/j.phymed.2011.06.014</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.phymed.2011.06.014" target="_blank" >10.1016/j.phymed.2011.06.014</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Acute bronchitis therapy with ivy leaves extracts in a two-arm study: A double-blind, randomised study vs. an other ivy leaves extract

  • Original language description

    Ivy leaves extracts are authorised in medicinal products for the treatment of acute bronchitis. Different studies and the long experience on the market show safety and efficacy of this drug. A double-blind, randomised study was conducted to assess the efficacy and tolerability of ivy leaves soft extract with an other ivy leaves extract. 590 patients with acute bronchitis participated in this study. They were treated with test or comparator for 7 days (+/-1). The Bronchitis Severity Score (BSS) decreasedgradually and to a similar extent from Day 1 to Day 7 in both treatment groups. Starting from values of 6.2-6.3 +/- 1.2, the BSS decreased by approximately 4.7-4.9 points until Day 7, so that patients left the study with a mean BSS of 1.4-1.6. The BSS subscales cough, sputum, rhales/rhonchi, chest pain during coughing, and dyspnoea improved to a similar extent in both treatment groups. Overall, 2.7% of patients (per group and overall) experienced an adverse event, all of which were non-

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FO - Dermatology and venereology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2011

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Phytomedicine

  • ISSN

    0944-7113

  • e-ISSN

  • Volume of the periodical

    18

  • Issue of the periodical within the volume

    13

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    5

  • Pages from-to

    1105-1109

  • UT code for WoS article

    000297187200001

  • EID of the result in the Scopus database